Skip to main content

Modern and new drug development is a team sport

Our drug development teams have collaborated with our partners on well over 250 programs, across all stages of drug development life cycle and in every therapeutic area from oncology to rare diseases. Acting as your dedicated stewards, our best-practice, quantitative systems and integrated approach delivers significant time and cost savings while accelerating regulatory and commercial success. From clinical pharmacology to pharmacometrics to regulatory submission and strategy and market access, we have 650+ leading experts throughout the world who are dedicated to achieving your goals. Build your drug development dream team with Certara.

How we help our clients

Go to  Data Programming & Support

PK/PD Data Programming & Support

We offer fast turnaround programming to support all phases of drug discovery and development in MIDD (Model–informed drug development).

Go to Data Programming & Support
Go to Biostatistics

Biostatistics and Statistical Programming

Analytical Support from Phase I through Submission and Beyond

Go to Biostatistics
Go to CODEx

CODEx Clinical Trial Outcomes Databases

Quantify how your drug’s safety/efficacy
compares to the competition

Go to CODEx
Go to DIDB®

Drug Interactions Database (DIDB®)

DIDB is internationally recognized as an authoritative, unbiased, transparent research tool for drug interactions, used by 210 organizations from over 40 countries.

Go to DIDB®

Creating unquestionable value for our partners is our #1 priority

Leveraging our best-in-class capabilities in modeling & simulation, regulatory science, and market access, we work alongside your team to inform critical decisions and set you up for regulatory and commercial success.

Agility, communication, quality, and trust are paramount to the success of our partnerships.  Together with you, we are one, integrated and cohesive team that anticipates risks, creates a robust strategy, and delivers with seamless implementation.

Contact us
Creating unquestionable value for our partners is our #1 priority
Your first choice partner
Your first choice partner

Why do global pharmaceutical companies, biotechnology startups, and venture capital and private equity firms alike choose Certara?

  • Our quantitative-driven approach.  Using modeling and simulation across the entire drug development life cycle, we help to de-risk your program, increase confidence in critical decisions, and help you reach your goals, smarter and faster
  • Our people.  We have the most experienced (and largest) team of experts with clinical pharmacologists, pharmacometricians, and regulatory scientists and writers, that is dedicated to achieve your success
  • Our proven track record.  We have a library of case studies on our successful collaborations in oncology, rare diseases, infectious diseases, neurodegenerative diseases, and more.
Start a conversation

How can we help you?

Contact us today to discuss how we can accelerate your program.